Published in Ann Intern Med on February 01, 1987
Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care | NCT00440687
Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD (RECUT) | NCT02386735
A Study Into Airways Disease Case Finding and Management (ASSIST) | NCT03355677
BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax (1997) 9.69
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax (2002) 8.77
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax (2003) 4.53
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax (2000) 4.45
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax (2003) 4.02
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev (2001) 3.58
COPD exacerbations .1: Epidemiology. Thorax (2006) 2.94
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax (2004) 2.78
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax (2003) 2.68
Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ (2012) 2.33
Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax (2003) 2.33
Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids. Chest (2013) 2.12
Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax (2003) 2.11
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis (2007) 2.11
COPD exacerbations . 2: aetiology. Thorax (2006) 1.90
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial. Respir Res (2011) 1.89
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med (2012) 1.85
Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax (2002) 1.79
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. Eur Respir J (2011) 1.68
Randomized controlled trial of an internet-based versus face-to-face dyspnea self-management program for patients with chronic obstructive pulmonary disease: pilot study. J Med Internet Res (2008) 1.61
Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients. Ann Intensive Care (2014) 1.53
Incidence and treatment results of laryngopharyngeal reflux in chronic obstructive pulmonary disease. Eur Arch Otorhinolaryngol (2009) 1.51
Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes (2006) 1.49
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax (2001) 1.48
Chronic obstructive pulmonary disease . 7: Management of COPD. Thorax (2003) 1.47
Study on risk factors and phenotypes of acute exacerbations of chronic obstructive pulmonary disease in Guangzhou, China-design and baseline characteristics. J Thorac Dis (2015) 1.39
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med (2009) 1.37
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med (2014) 1.37
Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease. J Clin Microbiol (2007) 1.33
Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. Can Respir J (2008) 1.28
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax (2001) 1.27
Role of macrolide therapy in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.24
Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax (2003) 1.23
An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir Res (2006) 1.22
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax (2001) 1.21
Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med (1997) 1.20
Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.20
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax (2003) 1.20
Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.18
Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation (2014) 1.18
Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care (2010) 1.17
Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax (2003) 1.14
COPD exacerbations.5: management. Thorax (2006) 1.14
Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res (2007) 1.14
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India (2013) 1.13
Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res (2007) 1.12
Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review. BMC Med (2008) 1.11
Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD. J Clin Immunol (2009) 1.10
Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Respir J (2007) 1.09
Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Int J Chron Obstruct Pulmon Dis (2012) 1.08
Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax (2006) 1.04
Perspectives that influence action plans for chronic obstructive pulmonary disease. Can Respir J (2006) 1.04
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations. Int J Chron Obstruct Pulmon Dis (2011) 1.04
Markers of exacerbation severity in chronic obstructive pulmonary disease. Respir Res (2006) 1.04
Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J Chron Obstruct Pulmon Dis (2009) 1.04
Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status. Lung (2011) 1.04
Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 1.04
Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial [ISRCTN17802078]. Crit Care (2005) 1.04
Pneumonia in South-East Asia Region: public health perspective. Indian J Med Res (2012) 1.04
The Christmas season as a risk factor for chronic obstructive pulmonary disease exacerbations. Can Respir J (2010) 1.03
Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med (2009) 1.02
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2014) 1.02
Intermediate care--Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline. Thorax (2006) 1.02
Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol (2007) 1.02
Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microbiol Infect Dis (2009) 1.01
Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis (2012) 1.01
Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines. Br J Gen Pract (2006) 1.01
Impact of acetazolamide use in severe exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation. Int J Crit Illn Inj Sci (2015) 1.00
Airways inflammation and treatment during acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis (2008) 1.00
Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. Antimicrob Agents Chemother (1990) 1.00
Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis. Thorax (2001) 0.99
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial. Respir Res (2007) 0.98
Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors. BMC Pulm Med (2014) 0.97
Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol (2013) 0.97
Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci (2012) 0.95
Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. Thorax (2006) 0.94
Antibiotics in chronic obstructive pulmonary disease. BMJ (1994) 0.94
Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation. Cell Mol Life Sci (2013) 0.94
Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Respir Res (2009) 0.93
Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One (2011) 0.93
Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? Thorax (2006) 0.93
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. Thorax (1998) 0.92
Factors influencing airway inflammation in chronic obstructive pulmonary disease. Thorax (2000) 0.92
Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil. Antimicrob Agents Chemother (2006) 0.91
Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med (2009) 0.91
Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med (2008) 0.91
Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. BMC Infect Dis (2008) 0.90
Guidelines for the assessment and management of chronic obstructive pulmonary disease. Canadian Thoracic Society Workshop Group. CMAJ (1992) 0.90
Strategies for improving outcomes of COPD exacerbations. Int J Chron Obstruct Pulmon Dis (2006) 0.90
Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions. Tex Heart Inst J (1990) 0.90
A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.90
The causes and consequences of seasonal variation in COPD exacerbations. Int J Chron Obstruct Pulmon Dis (2014) 0.90
Respiratory infection by Corynebacterium striatum: epidemiological and clinical determinants. New Microbes New Infect (2014) 0.89
Can a self-management education program for patients with chronic obstructive pulmonary disease improve quality of life? Can Respir J (2011) 0.89
Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation. Postgrad Med J (2004) 0.89
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med (1995) 6.49
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48
Mortality in COPD: Role of comorbidities. Eur Respir J (2006) 4.14
The challenge of tuberculosis: statements on global control and prevention. Lancet (1995) 3.19
Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 3.03
Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax (1977) 2.85
Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J (2006) 2.85
Airways obstruction and the risk for lung cancer. Ann Intern Med (1987) 2.77
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Airway closure as a function of age. Respir Physiol (1969) 2.53
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol (2000) 2.50
Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet (1992) 2.40
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Tuberculosis surveillance in immigrants to Manitoba. CMAJ (1990) 2.32
Bacteriuria in elderly institutionalized men. N Engl J Med (1983) 2.20
Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis (1987) 2.10
The association of urinary tract infection with sexual intercourse. J Infect Dis (1982) 2.05
Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med (2001) 2.03
Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis (1989) 2.03
A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians. Am J Public Health (1986) 2.01
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol (2001) 1.98
The postantibiotic effect: a review of in vitro and in vivo data. DICP (1991) 1.91
A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother (2000) 1.89
Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 1.87
A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch Pediatr Adolesc Med (2000) 1.85
A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment cases. Can J Public Health (1978) 1.84
Characterization of coagulase-negative staphylococci from urinary tract specimens. J Clin Microbiol (1983) 1.81
Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med (1982) 1.80
Identification of microsporidia in stool specimens by using PCR and restriction endonucleases. J Clin Microbiol (1995) 1.79
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med (1974) 1.74
Some aspects of medicine in the Greek Bronze age. Med Hist (1970) 1.73
Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax (2001) 1.72
Where Manitoba children obtain their cigarettes. CMAJ (1987) 1.71
Radiological changes after withdrawal from asbestos exposure. Br J Ind Med (1979) 1.70
Regional lung function in patients with chronic bronchitis. Clin Sci (1968) 1.69
Influence of mucoidy on antibody coating of Pseudomonas aeruginosa. J Infect Dis (1979) 1.67
The effect of age on risk factors for ischemic heart disease: the Manitoba Follow-Up Study, 1948-1993. Ann Epidemiol (1998) 1.66
A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med (1979) 1.64
Survey of anaerobic susceptibility patterns in Canada. Antimicrob Agents Chemother (1986) 1.60
Distribution of pulmonary perfusion in erect man. J Appl Physiol (1966) 1.57
Intraabdominal infection: a review. Clin Infect Dis (1994) 1.54
Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep (1999) 1.53
Percolation on heterogeneous networks as a model for epidemics. Math Biosci (2002) 1.52
Arthritis associated with Salmonella infections. Ann Rheum Dis (1970) 1.50
New primers for promising single-copy genes in fungal phylogenetics and systematics. Persoonia (2009) 1.49
Optimal use of the cytocentrifuge for recovery and diagnosis of Pneumocystis carinii in bronchoalveolar lavage and sputum specimens. J Clin Microbiol (1988) 1.48
Cystic fibrosis--immunological reactions to A. fumigatus and common allergens. Clin Allergy (1975) 1.48
Febrile urinary infection in the institutionalized elderly. Am J Med (1996) 1.47
Christmas candy maker's asthma. IgG4-mediated pectin allergy. Chest (1992) 1.46
Income level and asthma prevalence and care patterns. Am J Respir Crit Care Med (1997) 1.44
Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest (1998) 1.42
Urinary antibody level and survival in bacteriuric institutionalized older subjects. J Am Geriatr Soc (1998) 1.40
Comparison of responses to methacholine and cold air in patients suspected of having asthma. Chest (1989) 1.40
North American blastomycosis in Central Canada. A review of 36 cases. Can Med Assoc J (1972) 1.39
Selective bowel decontamination does not alter hepatic regeneration in rats. Gastroenterology (1992) 1.39
Photo quiz. Symmetric peripheral gangrene. Clin Infect Dis (1996) 1.37
Biotyping of Escherichia coli by a simple multiple-inoculation agar plate technique. J Clin Microbiol (1979) 1.36
Prevalence of asthma symptoms among adults aged 20-44 years in Canada. CMAJ (2001) 1.33
Exposure and sensitization to cat dander: asthma and asthma-like symptoms among adults. J Allergy Clin Immunol (1999) 1.31
The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest (1991) 1.31
Urinary tract infection localization in women. JAMA (1978) 1.30
Trends in physician-diagnosed asthma prevalence in Manitoba between 1980 and 1990. Chest (1993) 1.27
Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. The Manitoba Diabetic Urinary Infection Study Group. Clin Infect Dis (1995) 1.27
Effect of inspiratory flow rate on regional distribution of inspired gas. J Appl Physiol (1969) 1.27
Regional structure and function in bronchiectasis. A correlative study using bronchography and 133Xe. Am Rev Respir Dis (1968) 1.26
Epidemiologic features of cerebrovascular disease in Manitoba: incidence by age, sex and residence, with etiologic implications. Can Med Assoc J (1975) 1.24
The emergency department is a determinant point of contact of tuberculosis patients prior to diagnosis. Int J Tuberc Lung Dis (2002) 1.24
Health care utilization in the 10 years prior to diagnosis in obstructive sleep apnea syndrome patients. Sleep (1999) 1.24
The use of health-care resources in obesity-hypoventilation syndrome. Chest (2001) 1.24
The association of bacteriuria with resident characteristics and survival in elderly institutionalized men. Ann Intern Med (1987) 1.24
Group C streptococcal meningitis in an adult. Probable acquistion from a horse. Arch Intern Med (1980) 1.23
Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency. Antimicrob Agents Chemother (1986) 1.23
Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis (1996) 1.23
The natural history of primary first-degree atrioventricular heart block. N Engl J Med (1986) 1.23
Characterization of bacteroides melaninogenicus. J Clin Microbiol (1976) 1.21
Therapy for acute cystitis in adult women. Randomized comparison of single-dose sulfisoxazole vs trimethoprim-sulfamethoxazole. JAMA (1982) 1.21
Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med (1995) 1.20
Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country. Eur Respir J (2011) 1.17
Tuberculosis status and social adaptation of Indochinese refugees. Int Migr Rev (1987) 1.17
Human lung homotransplantation. Can Med Assoc J (1966) 1.16
Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol (2006) 1.16
Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med (2000) 1.15
The natural history of electrocardiographic preexcitation in men. The Manitoba Follow-up Study. Ann Intern Med (1992) 1.15
Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient. Rev Infect Dis (1986) 1.14
Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med (1996) 1.14
Ventilatory response to sustained hypoxia in normal adults. J Appl Physiol (1985) (1986) 1.14
Prophylaxis of recurrent urinary tract infection in female patients. Efficacy of low-dose, thrice-weekly therapy with trimethoprim-sulfamethoxazole. JAMA (1979) 1.13
Occupational asthma in adults in six Canadian communities. Am J Respir Crit Care Med (2000) 1.13
Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. J Clin Epidemiol (1998) 1.13
Endogenous opiates and chemical control of breathing in humans. Am Rev Respir Dis (1980) 1.12
The Canadian Lung Association and International Health. Bull Int Union Tuberc Lung Dis (1988) 1.12
A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. N Engl J Med (1986) 1.12
Long-term oxygen therapy. Ann Intern Med (1983) 1.11